Bladder Cancer
Conditions
Keywords
bladder cancer
Brief summary
The study seeks to delve into the firsthand experiences of patients diagnosed with bladder cancer who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals. By joining this clinical trial, individuals have the unique opportunity to contribute to the betterment of future bladder cancer patients and play an active role in advancing medical research.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient has self-identified as planning to enroll in a clinical trial * Patient has been diagnosed with bladder cancer * Patient is a minimum of 18 years or older
Exclusion criteria
* Patient does not understand, sign, and return consent form * Inability to perform regular electronic reporting * Patient is pregnant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of patients who decide to participate in a bladder cancer clinical research | 3 months |
| Rate of patients who remain in bladder cancer clinical research to trial completion | 12 months |
Countries
United States
Contacts
Primary ContactMichael B Gill
Outcome results
None listed